Aelis Farma (France) Performance
| AELIS Stock | 1.16 0.06 4.92% |
The firm shows a Beta (market volatility) of 1.79, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aelis Farma will likely underperform. At this point, Aelis Farma SA has a negative expected return of -0.33%. Please make sure to confirm Aelis Farma's value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if Aelis Farma SA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Aelis Farma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
| Begin Period Cash Flow | 4.5 M | |
| Total Cashflows From Investing Activities | -212 K |
Aelis |
Aelis Farma Relative Risk vs. Return Landscape
If you would invest 199.00 in Aelis Farma SA on December 21, 2024 and sell it today you would lose (83.00) from holding Aelis Farma SA or give up 41.71% of portfolio value over 90 days. Aelis Farma SA is generating negative expected returns and assumes 11.0242% volatility on return distribution over the 90 days horizon. Simply put, 98% of stocks are less volatile than Aelis, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Aelis Farma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aelis Farma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aelis Farma SA, and traders can use it to determine the average amount a Aelis Farma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0303
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AELIS |
Estimated Market Risk
| 11.02 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aelis Farma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aelis Farma by adding Aelis Farma to a well-diversified portfolio.
Aelis Farma Fundamentals Growth
Aelis Stock prices reflect investors' perceptions of the future prospects and financial health of Aelis Farma, and Aelis Farma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aelis Stock performance.
| Return On Equity | -1.0 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (2.04) % | |||
| Operating Margin | (1.01) % | |||
| Current Valuation | 102.61 M | |||
| Shares Outstanding | 12.5 M | |||
| Price To Book | 5.85 X | |||
| Price To Sales | 21.46 X | |||
| Revenue | 9.07 M | |||
| EBITDA | (6.7 M) | |||
| Cash And Equivalents | 24.71 M | |||
| Total Debt | 3.26 M | |||
| Book Value Per Share | 1.91 X | |||
| Cash Flow From Operations | 18.97 M | |||
| Earnings Per Share | 0.32 X | |||
| Total Asset | 28.31 M | |||
About Aelis Farma Performance
Assessing Aelis Farma's fundamental ratios provides investors with valuable insights into Aelis Farma's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Aelis Farma is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Aelis Farma SA performance evaluation
Checking the ongoing alerts about Aelis Farma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aelis Farma SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aelis Farma SA generated a negative expected return over the last 90 days | |
| Aelis Farma SA has high historical volatility and very poor performance | |
| Aelis Farma SA may become a speculative penny stock |
- Analyzing Aelis Farma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aelis Farma's stock is overvalued or undervalued compared to its peers.
- Examining Aelis Farma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aelis Farma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aelis Farma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aelis Farma's stock. These opinions can provide insight into Aelis Farma's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Aelis Stock Analysis
When running Aelis Farma's price analysis, check to measure Aelis Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aelis Farma is operating at the current time. Most of Aelis Farma's value examination focuses on studying past and present price action to predict the probability of Aelis Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aelis Farma's price. Additionally, you may evaluate how the addition of Aelis Farma to your portfolios can decrease your overall portfolio volatility.